B. Mark Evers, MD, FACS – Distinguished Lecture Series

“Neurotensin—New Tricks for an Old Hormone” and

“A Brief Commentary on Pursuing NCI Designation and Changing a Culture in Kentucky”

B. Mark Evers, MD, FACS

Director, Markey Cancer Center
Professor and Vice-Chair for Research, Department of Surgery
McDowell Foundation Endowed Chair
Physician-in-Chief, Oncology Service Line
University of Kentucky

Register here

Dr. Evers is an accomplished surgical oncologist, cancer researcher, educator, and administrator. He was recruited to the University of Kentucky (UK) in 2009 as Director of the UK Markey Cancer Center (MCC), Physician-in-chief of the Oncology Service Line, and Vice-Chair in the Department of Surgery. Under his leadership, the MCC achieved NCI designation in 2013 and successfully competed for the renewal of its Cancer Center Support Grant (P30) in 2018. Prior to his recruitment to UK, Dr. Evers was the Robertson-Poth Distinguished Chair in General Surgery and Director of the University of Texas Medical Branch (UTMB) Cancer Center.

Dr. Evers has been continuously funded by the NIH for over 30 years and has published more than 450 peer-reviewed publications, book chapters, and reviews. Throughout his career, he has received more than 30 awards and held numerous leadership positions in national and international organizations.  He is an elected member of the National Academy of Medicine (NAM) and has held leadership positions in a number of surgical societies.

View the University of Illinois Cancer Center Distinguished Lecture Series schedule here.